FDA: APPROVED CAMZYOS (MAVACAMTEN) CAPSULES AS FIRST TREATMENT FOR CHILDREN WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - WEBSITE 30-SEP-2026 02:42 PM ET